Alkem Laboratories Limited (BOM:539523)
India · Delayed Price · Currency is INR 5,074.15
-81.85 (-1.59%)
At close: Oct 28, 2026
Alkem Laboratories Market Cap
Alkem Laboratories has a market cap or net worth of 606.19 billion as of October 28, 2026. Its market cap has decreased by 7.41% in one year.
Market Cap
606.19B
Enterprise Value
591.34B
Revenue
150.81B
Global Rank
n/a
Country Rank
n/a
PE Ratio
28.12
ChartMarket Cap Chart
Since December 23, 2015, Alkem Laboratories's market cap has increased from 165.20B to 606.19B, an increase of 266.94%. That is a compound annual growth rate of 12.72%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 28, 2026 | 606.19B | -7.93% |
| Dec 31, 2025 | 658.38B | -2.26% |
| Dec 31, 2024 | 673.62B | 8.29% |
| Dec 29, 2023 | 622.05B | 73.15% |
| Dec 30, 2022 | 359.26B | -17.09% |
| Dec 31, 2021 | 433.31B | 23.85% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Zydus Lifesciences | 1.16T |
| Laurus Labs | 1.11T |
| Cipla | 1.09T |
| Mankind Pharma | 954.85B |
| Aurobindo Pharma | 914.85B |
| Glenmark Pharmaceuticals | 628.12B |
| Alkem Laboratories | 601.41B |
| Ipca Laboratories | 491.83B |